Synthetic Modulators of the Vitamin D Receptor: From Structural Innovation to Disease-Specific Applications. [PDF]
BiomoleculesNguyen TT +4 more
europepmc +1 more source
Eldecalcitol ameliorates diabetic osteoporosis and glucolipid metabolic disorder by promoting Treg cell differentiation through SOCE. [PDF]
Cell Mol Life SciJiang Y +8 more
europepmc +1 more source
Vitamin D therapy in chronic kidney disease: a critical appraisal of clinical trial evidence. [PDF]
Clin Kidney JYeung WG, Toussaint ND, Badve SV.
europepmc +1 more source
Preventing Loss of Femoral Periprosthetic Bone Mineral Density in Cementless Total Hip Arthroplasty Using a Tapered Wedge Stem: A Retrospective, Cohort Study in Osteoporotic Patients Treated with Denosumab. [PDF]
CureusKamo K +7 more
europepmc +1 more source
Eldecalcitol replaces endogenous calcitriol but does not fully compensate for its action in vivo
Journal of Steroid Biochemistry and Molecular Biology, 2014 Calcitriol (1α,25-dihydroxyvitamin D3, 1α,25(OH)2D3) is an essential hormone that works in cooperation with parathyroid hormone (PTH) and fibroblast growth factor-23 (FGF-23) to regulate calcium and phosphorus homeostasis.
Hitoshi Saito, Suguru Harada
exaly +2 more sources
Relationship between the effect of eldecalcitol and serum 25(OH)D level
Journal of Steroid Biochemistry and Molecular Biology, 2014 In previous studies, we demonstrated that 12-month treatment with 0.75μg/day eldecalcitol increased bone mineral density in osteoporotic patients regardless of serum 25-hydroxyvitamin D (25(OH)D) level, and in a 3-year randomized double-blind clinical ...
Hitoshi Saito, Toshio Matsumoto
exaly +2 more sources
Large-Scale Synthesis of Eldecalcitol
Organic Process Research and Development, 2021 Hyunik Shin
exaly +2 more sources
Related searches:
Eldecalcitol inhibits the progression of oral cancer by suppressing the expression of GPx‐1
Oral Diseases, 2023Yupu Lu, Yuying Kou, Minqi Li
exaly